Analyst expects continued growth for Lundbeck's key products
According one analyst, Lundbeck’s first-quarter performance will be driven by a solid underlying demand for the company’s strategic key products.
by marketwire, translated by christian radich hoffman
The prospect of sales growth at Lundbeck is once again within reach, assesses Søren Løntoft hansen, senior equity analyst at investment bank Sydbank, in anticipation of the company’s first-quarter report on Wednesday.
Already a subscriber?Log in here
Read the whole article
Get access for 14 days for free. No credit card is needed, and you will not be automatically signed up for a paid subscription after the free trial.
With your free trial you get:
Get full access for you and your coworkers
Start a free company trial todayRelated articles
Lundbeck sells rights to three development programs
For subscribers
Lundbeck and Otsuka win FDA approval for schizophrenia drug
For subscribers
